PubRank

Takeshi Sugaya

Author PubWeight™ 117.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011 2.68
2 Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg 2012 2.39
3 Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 2010 2.06
4 Renal L-type fatty acid--binding protein in acute ischemic injury. J Am Soc Nephrol 2007 1.98
5 Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004 1.91
6 Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003 1.79
7 Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med 2010 1.74
8 Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006 1.67
9 Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults. Circ J 2011 1.65
10 Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol 2004 1.61
11 Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 2004 1.57
12 Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004 1.56
13 Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol 2004 1.55
14 Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 2004 1.55
15 Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2004 1.53
16 Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004 1.48
17 Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J 2005 1.45
18 Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium. Arterioscler Thromb Vasc Biol 2004 1.45
19 Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 2002 1.37
20 Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion. Shock 2009 1.32
21 Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 2005 1.31
22 Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002 1.25
23 Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. J Biol Chem 2003 1.25
24 Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care 2011 1.24
25 Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care 2009 1.23
26 Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006 1.22
27 Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol 2009 1.20
28 Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 2012 1.19
29 Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury. Crit Care Med 2006 1.19
30 Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol Renal Physiol 2003 1.17
31 Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med 2005 1.16
32 Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2003 1.15
33 Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 2008 1.13
34 Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006 1.12
35 Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 2009 1.12
36 Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006 1.10
37 Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 2012 1.09
38 SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med 2011 1.08
39 Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J 2005 1.01
40 Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice. Nephrol Dial Transplant 2008 1.01
41 Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res 2004 0.99
42 Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease. Am J Med Sci 2007 0.99
43 Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am J Pathol 2006 0.99
44 Electrophysiological properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice. Hypertension 2005 0.96
45 Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clin Exp Nephrol 2010 0.96
46 Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 2006 0.95
47 Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. Hypertens Res 2002 0.94
48 In vivo gene delivery by cationic tetraamino fullerene. Proc Natl Acad Sci U S A 2010 0.93
49 Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Lab Invest 2008 0.93
50 Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. Antioxid Redox Signal 2005 0.93
51 Novel urinary biomarkers in early diabetic kidney disease. Curr Diab Rep 2014 0.92
52 Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2004 0.92
53 Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. J Am Soc Nephrol 2007 0.92
54 Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin Exp Nephrol 2005 0.91
55 Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am J Pathol 2011 0.91
56 Biphasic regulation of Na+-HCO3- cotransporter by angiotensin II type 1A receptor. Hypertension 2002 0.90
57 The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation. Am J Pathol 2009 0.90
58 Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Exp Nephrol 2007 0.90
59 GW501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice. PLoS One 2011 0.89
60 Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am J Pathol 2009 0.89
61 Induction of glia maturation factor-beta in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities. J Biol Chem 2003 0.89
62 Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice. J Am Soc Nephrol 2002 0.88
63 Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner. Am J Pathol 2006 0.88
64 A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol 2006 0.88
65 Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria. Diabetes Metab Res Rev 2006 0.88
66 Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. Am J Hypertens 2007 0.87
67 Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway. J Immunol 2002 0.87
68 An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J 2003 0.87
69 Amelioration of cisplatin-induced acute renal injury by renal progenitor-like cells derived from the adult rat kidney. Cell Transplant 2008 0.86
70 Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy. Nephron Clin Pract 2009 0.86
71 Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrol Dial Transplant 2011 0.86
72 Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice. Nephrology (Carlton) 2011 0.86
73 Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease. Am J Nephrol 2006 0.86
74 Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care. Curr Opin Crit Care 2010 0.86
75 Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine. J Biol Chem 2005 0.86
76 Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Exp Nephrol 2003 0.86
77 Urinary liver type fatty acid binding protein in diabetic nephropathy. Clin Chim Acta 2013 0.86
78 Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy. Nephrol Dial Transplant 2010 0.85
79 Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model. Am J Physiol Renal Physiol 2012 0.84
80 Blunted tubuloglomerular feedback by absence of angiotensin type 1A receptor involves neuronal NOS. Hypertension 2002 0.84
81 Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease. Am J Med Sci 2010 0.84
82 Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy. Kidney Blood Press Res 2010 0.84
83 Biphasic regulation of renal proximal bicarbonate absorption by luminal AT(1A) receptor. J Am Soc Nephrol 2003 0.84
84 Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor. J Cardiovasc Pharmacol 2003 0.83
85 Urinary liver-type fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy. Am J Nephrol 2005 0.83
86 Urinary excretion of liver fatty acid-binding protein in health-check participants. Clin Exp Nephrol 2005 0.82
87 Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol Dial Transplant 2003 0.81
88 Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease. Am J Med Sci 2005 0.80
89 Poly(ADP-ribose) polymerase-1 enhances transcription of the profibrotic CCN2 gene. J Am Soc Nephrol 2008 0.80
90 Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clin Exp Nephrol 2007 0.80
91 A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1. Am J Physiol Renal Physiol 2013 0.79
92 Glomerular repair retardation via blocking of angiotensin II type 1a receptor pathway in a mouse glomerulonephritis model. Nephron Exp Nephrol 2013 0.79
93 Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease. Eur J Clin Invest 2010 0.79
94 High glucose increases metallothionein expression in renal proximal tubular epithelial cells. Exp Diabetes Res 2011 0.79
95 Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-deficient mice. Circ J 2007 0.79
96 Identification of cis-regulatory sequences in the human angiotensinogen gene by transgene coplacement and site-specific recombination. Mol Cell Biol 2005 0.79
97 Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia. Am J Nephrol 2006 0.79
98 Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury. Nephron Exp Nephrol 2008 0.78
99 [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan]. Rinsho Byori 2013 0.78
100 Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice. Clin Exp Hypertens 2005 0.78
101 [L-type fatty acid binding protein (L-FABP) and kidney disease]. Rinsho Byori 2014 0.78
102 [¹⁸F-fluorodeoxyglucose PET/CT and small bowel endoscopy in a patient with small bowel leiomyoma]. Nihon Shokakibyo Gakkai Zasshi 2012 0.78
103 Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury. Hypertension 2012 0.78
104 Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation. Am J Physiol Renal Physiol 2014 0.78
105 [Prophylaxis and treatment of NSAID-related peptic ulceration: present status and prospects]. Nihon Rinsho 2011 0.77
106 Quantification of L-type fatty acid binding protein in the urine of preterm neonates. Early Hum Dev 2005 0.77
107 Ulcerative Colitis-associated Cancer/Dysplasia Detected Using Surveillance Colonoscopy Performed in the Clinical Remission Phase: A Report of Five Cases. Intern Med 2016 0.77
108 Moderate-intensity single exercise session does not induce renal damage. J Clin Lab Anal 2013 0.77
109 Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease. Heart Vessels 2014 0.77
110 A nuclear receptor, hepatocyte nuclear factor 4, differently contributes to the human and mouse angiotensinogen promoter activities. J Recept Signal Transduct Res 2010 0.76
111 IFN-inducible protein 10 (CXCL10) regulates tubular cell proliferation in renal ischemia-reperfusion injury. Nephron Exp Nephrol 2008 0.76
112 Angiotensin II regulates liver regeneration via type 1 receptor following partial hepatectomy in mice. Biol Pharm Bull 2008 0.76
113 Amelioration of angiotensin II-induced salt-sensitive hypertension by liver-type fatty acid-binding protein in proximal tubules. Hypertension 2013 0.75
114 [Q & A. A raised duodenal lesion associated with anemia and upper abdominal pain]. Nihon Shokakibyo Gakkai Zasshi 2013 0.75
115 Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy. Metabolism 2009 0.75
116 Cigarette smoking affects urinary liver-type fatty acid-binding protein concentration in patients with early diabetic nephropathy. Diabetes Care 2006 0.75
117 Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int 2016 0.75
118 The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases. Hepatogastroenterology 2012 0.75
119 [Urinary excretion of liver type fatty acid binding protein (L-FABP)]. Nihon Rinsho 2004 0.75
120 Renoprotective effect of telmisartan in patients with chronic kidney disease. Clin Exp Hypertens 2008 0.75
121 Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease. Clin Chem Lab Med 2016 0.75
122 The biomarker for CKD: urinary L-FABP - from molecular function to clinical significance. Nihon Yakurigaku Zasshi 2015 0.75
123 Delayed phosphorylation of p38 mitogen-activated protein kinase in the AT1a knock-out mouse striatal neurons during middle cerebral artery occlusion and reperfusion. Neurosci Lett 2003 0.75
124 [A case of acute pancreatitis with systemic lupus erythematosus]. Nihon Shokakibyo Gakkai Zasshi 2010 0.75
125 L-type fatty acid binding protein transgenic mouse as a novel tool to explore cytotoxicity to renal proximal tubules. Drug Metab Pharmacokinet 2008 0.75
126 [Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease]. Rinsho Byori 2003 0.75
127 Endoscopic balloon dilation for stenotic lesions in Crohn's disease. Turk J Gastroenterol 2017 0.75
128 [Urinary liver type fatty acid binding protein (L-FABP)]. Nihon Rinsho 2010 0.75